Depression News

Depression among children did not increase substantially between 2004 and 2019, according to the results of a systematic review and meta-analysis published in JAMA Pediatrics.

The COVID-19 pandemic has been described by Anthony S. Fauci, MD, as “the most catastrophic acute infectious disease outbreak” in more than a century.

Suicidal behavior was associated with more than twice the risk for all-cause mortality in patients with major depressive disorder, as well as increased work loss and health care resource utilization, according to a Swedish study.

The impact of COVID-19 extends beyond those who get infected and evokes symptoms of anxiety, depression and PTSD in their families, according to two studies published in Annals of the American Thoracic Society.

Psychological distress may be linked to poor self-management of chronic kidney disease, according to a recently published study of patients with CKD who were not on dialysis.

Subcallosal cingulate gyrus deep brain stimulation was generally safe and significantly improved depressive symptoms in patients with treatment-resistant depression, with results sustained up to 7 years, according to research.

Continuing adjunctive antidepressant therapy for 52 weeks after depressive episode remission in patients with bipolar 1 disorder did not significantly delay further mood episodes vs. stopping treatment after 8 weeks, according to a study.

Anxiety and depression are prevalent psychiatric comorbidities among individuals with hemophilia, according to study results.

In dyads of Parkinson’s disease patients and caregivers, caregivers with a higher risk for depression were associated with patients’ lower quality of life and higher number of annual ED visits.

A dietary pattern with high intakes of chocolate, butter, added sugars, high-fat cheese and milk-based desserts along with low intakes of fruit and vegetables was linked to a greater risk for depression and anxiety symptoms, data show.